5-HT6 agonist 1

Compound 19 is a potent and metabolically stable 5-HT6 receptor agonist (Ki = 5 nM) . It demonstrates antidepressant-like and pro-cognitive activities in preclinical models, alongside an inhibitory effect on platelet aggregation, making it a useful research tool for neuropsychiatric and cardiovascular studies.